HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Read responses to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scott, N Articles by Coletta, P L Search for Related Content PubMed PubMed Citation Articles by Scott, N Articles by Coletta, P L Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Carcinoid Tumors

Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours

¹ Department of Pathology, St James’s University Hospital, United Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK
² Department of Molecular Medicine, St James’s University Hospital
³ Department of Surgery, St James’s University Hospital

Correspondence to:
Dr N Scott
Department of Pathology, St James’s University Hospital, Leeds LS9 7TF, UK; nigelscott50{at}hotmail.com Aims: To establish whether gastrin releasing peptide (GRP) and the GRP receptor (GRPR) are expressed together in gastrointestinal carcinoid tumours.

Methods: Twenty six carcinoid tumours from the stomach, small intestine, appendix, and colorectum were investigated by immunohistochemistry for GRP and GRPR.

Results: GRP was detected in nine of 19 tumours and GRPR in 22 of 26. Coexpression of both the ligand and receptor was seen in six of 19 cases. GRPR but not GRP was more strongly expressed in appendix and colonic tumours.

Conclusions: GRP and GRPR are produced by a large number of gastrointestinal carcinoid tumours. An autocrine/paracrine pathway may exist for GRP stimulated cell proliferation in some of these neoplasms, analogous to that seen in small cell anaplastic carcinoma of the lung.

Keywords: gastrin releasing peptide; gastrin releasing peptide receptor; immunohistochemistry; carcinoid; gastrointestinal

Abbreviations: GRP, gastrin releasing peptide; GRPR, gastrin releasing peptide receptor

This article has been cited by other articles:

				W. Guojun, G. Wei, O. Kedong, H. Yi, X. Yanfei, C. Qingmei, Z. Yankai, W. Jie, F. Hao, L. Taiming, et al. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo Endocr. Relat. Cancer, March 1, 2008; 15(1): 149 - 159. [Abstract] [Full Text] [PDF]

				R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42. [Abstract] [Full Text] [PDF]

				D. Cornelio, R Roesler, and G Schwartsmann Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy Ann. Onc., September 1, 2007; 18(9): 1457 - 1466. [Abstract] [Full Text] [PDF]

eLetters: